Overview

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Status:
Completed
Trial end date:
2017-05-04
Target enrollment:
Participant gender:
Summary
This phase Ib study investigates the safety and efficacy of performing a retinal vein cannulation with recombinant tissue Plasminogen Activator infusion into a retinal vein with the help of an updated dedicated surgical stabiliser for the treatment of central retinal vein occlusion.
Phase:
Phase 1
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Treatments:
Tissue Plasminogen Activator